Allergan, Pfizer Unit Reach Deal Over Generic Dry-Eye Drug
Allergan announced Thursday it has reached a deal with Pfizer-owned drugmaker InnoPharma to end litigation over patents protecting its dry-eye treatment Restasis, a month after Allergan transferred its Restasis patents to...To view the full article, register now.
Already a subscriber? Click here to view full article